GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » aap Implantate AG (HAM:AAQ1) » Definitions » Revenue

aap Implantate AG (HAM:AAQ1) Revenue : €11.83 Mil (TTM As of Jun. 2023)


View and export this data going back to 1999. Start your Free Trial

What is aap Implantate AG Revenue?

aap Implantate AG's revenue for the six months ended in Jun. 2023 was €5.86 Mil. Its revenue for the trailing twelve months (TTM) ended in Jun. 2023 was €11.83 Mil. aap Implantate AG's Revenue per Share for the six months ended in Jun. 2023 was €0.65. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was €1.66.

Warning Sign:

aap Implantate AG revenue per share has been in decline for the last 5 years.

During the past 12 months, the average Revenue per Share Growth Rate of aap Implantate AG was -24.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was -19.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was -11.20% per year. During the past 10 years, the average Revenue per Share Growth Rate was -10.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, aap Implantate AG's highest 3-Year average Revenue per Share Growth Rate was 9.20% per year. The lowest was -28.40% per year. And the median was -7.35% per year.


aap Implantate AG Revenue Historical Data

The historical data trend for aap Implantate AG's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

aap Implantate AG Revenue Chart

aap Implantate AG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.78 11.74 9.33 12.17 11.52

aap Implantate AG Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.97 6.20 5.55 5.96 5.86

Competitive Comparison of aap Implantate AG's Revenue

For the Medical Devices subindustry, aap Implantate AG's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


aap Implantate AG's Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, aap Implantate AG's Revenue distribution charts can be found below:

* The bar in red indicates where aap Implantate AG's Revenue falls into.



aap Implantate AG Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €11.83 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


aap Implantate AG  (HAM:AAQ1) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


aap Implantate AG Revenue Related Terms

Thank you for viewing the detailed overview of aap Implantate AG's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


aap Implantate AG (HAM:AAQ1) Business Description

Traded in Other Exchanges
Address
Lorenzweg 5, Berlin, DEU, 12099
aap Implantate AG develops, manufactures, and markets trauma products for orthopedics. The company classifies its products that are Trauma and Others. The product line of the company consists of a plating system under the brand LOQTEQ, and cannulated screws. The company's projects such as antibacterial silver coating technology and magnesium-based implants. It develops a plating system for the Shoulder, Knee, Elbow, Wrist, and Ankle Joint. The company sells its product directly to hospitals, syndicates, and hospital groups with the help of distributors.

aap Implantate AG (HAM:AAQ1) Headlines

No Headlines